Aligos Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 76.2M |
| FY2021 | 85.4M |
| FY2022 | 85.4M |
| FY2023 | 5.1M |
| FY2024 | 6.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 76.2M |
| FY2021 | 85.4M |
| FY2022 | 85.4M |
| FY2023 | 5.1M |
| FY2024 | 6.3M |